AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 158 CASES FROM THE FRENCH REGISTRY
Authors: MOREAU P FLEURY J BRICE P COLOMBAT P BOUABDALLAH R LIOURE B VOILLAT L CASASNOVAS O FRANCOIS S SADOUN A LAMY T LOTZ JP MUNCK JN DIVINE M FERME C PENY AM FRUCHART C ORIOL P OJEDA M REMAN O MILPIED N GISSELBRECHT C LEGROS M HAROUSSEAU JL
Citation: P. Moreau et al., EARLY INTENSIVE THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE - RETROSPECTIVE ANALYSIS OF 158 CASES FROM THE FRENCH REGISTRY, Bone marrow transplantation, 21(8), 1998, pp. 787-793
HIGH-DOSE MELPHALAN (HDM) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR MYELOMA (MM) PATIENTS WITH SEVERE RENAL-FAILURE - PHARMACOKINETIC STUDY - CORRELATION BETWEEN BIOLOGY AND CLINICS
Authors: LIOURE B WIHLM J DIMITROV Y ABDELKEFI A MALOISEL F LIU KL LAPLACE A MOULIN B OBERLING F
Citation: B. Lioure et al., HIGH-DOSE MELPHALAN (HDM) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR MYELOMA (MM) PATIENTS WITH SEVERE RENAL-FAILURE - PHARMACOKINETIC STUDY - CORRELATION BETWEEN BIOLOGY AND CLINICS, Bone marrow transplantation, 21, 1998, pp. 705-705
QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY
Authors: WATTEL E SOLARY E HECQUET B CAILLOT D IFRAH N BRION A MAHE B MILPIED N JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F BUZYN A HOANGNGOC L STOPPA AM GRATECOS N SADOUN A STAMATOULAS A TILLY H BRICE P MALOISEL F LIOURE B DESABLENS B PIGNON B ABGRALL JP LEPORRIER M DUPRIEZ B GUYOTAT D LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(4), 1998, pp. 1015-1024
G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) IN ACUTE MYELOID-LEUKEMIA (AML)
Authors: HAROUSSEAU JL WITZ F LIOURE B LEPRISE PY SOLARY E ABGRALL JF CASSASUS P AUDHUY B TRAVADE P CAHN JY
Citation: Jl. Harousseau et al., G-CSF AFTER INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) IN ACUTE MYELOID-LEUKEMIA (AML), British Journal of Haematology, 102(1), 1998, pp. 86-86
A PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED DURING AND AFTER INDUCTION TREATMENT FOR DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS
Authors: WITZ F SADOUN A PERRIN MC BERTHOU C BRIERE J CAHN JY LIOURE B WITZ B FRANCOIS S DESABLENS B PIGNON B LEPRISE PY AUDHUY B CAILLOT D CASASSUS P DELAIN M CHRISTIAN B TELLIER Z POLIN V HURTELOUP P HAROUSSEAU JL
Citation: F. Witz et al., A PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED DURING AND AFTER INDUCTION TREATMENT FOR DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS, Blood, 91(8), 1998, pp. 2722-2730
USE OF DONOR T-LYMPHOCYTES EXPRESSING HERPES-SIMPLEX THYMIDINE KINASEIN ALLOGENEIC BONE-MARROW TRANSPLANTATION - A PHASE I-II STUDY
Authors: TIBERGHIEN P CAHN JY BRION A DECONINCK E RACADOT E HERVE P MILPIED N LIOURE B GLUCKMAN E BORDIGONI P JACOB W CHIANG YW MARCUS S REYNOLDS C LONGO D
Citation: P. Tiberghien et al., USE OF DONOR T-LYMPHOCYTES EXPRESSING HERPES-SIMPLEX THYMIDINE KINASEIN ALLOGENEIC BONE-MARROW TRANSPLANTATION - A PHASE I-II STUDY, Human gene therapy, 8(5), 1997, pp. 615-624
INTERFERON-ALPHA-2B IN THE MANAGEMENT OF PATIENTS WITH RELAPSED AND OR REFRACTORY HODGKINS-DISEASE/
Authors: MALOISEL F VOILLAT L CHENARD MP BOEHN A LIOURE B OBERLING F
Citation: F. Maloisel et al., INTERFERON-ALPHA-2B IN THE MANAGEMENT OF PATIENTS WITH RELAPSED AND OR REFRACTORY HODGKINS-DISEASE/, Annals of oncology, 8(4), 1997, pp. 405-406
UNUSUAL CYTOGENETIC EVOLUTION IN CML TREATED WITH INTERFERON-ALPHA
Authors: MALOISEL F LAPLACE A UETTWILLER F LIOURE B OBERLING F
Citation: F. Maloisel et al., UNUSUAL CYTOGENETIC EVOLUTION IN CML TREATED WITH INTERFERON-ALPHA, Leukemia, 11(6), 1997, pp. 893-894
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA
Authors: GUARDIOLA P ESPEROU H CAZALS D IFRAH N JOUET JP BUZYN A SUTTON L GRATECOS N TILLY H LIOURE B GLUCKMAN E
Citation: P. Guardiola et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA, Experimental hematology, 25(8), 1997, pp. 202-202
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION - LONG-TERM RESULTS FOR 42 PATIENTS CONDITIONED WITH AN INTENSIFIED REGIMEN (TBI, HIGH-DOSE ARA-C AND MELPHALAN)
Authors: DECONINCK E CAHN JY MILPIED N JOUET JP VERNANT JP ESPEROU H LIOURE B BORDIGONI P LEBLOND V TROUSSARD X CAILLOT D CORDONNIER JM HERVE P
Citation: E. Deconinck et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION - LONG-TERM RESULTS FOR 42 PATIENTS CONDITIONED WITH AN INTENSIFIED REGIMEN (TBI, HIGH-DOSE ARA-C AND MELPHALAN), Bone marrow transplantation, 20(9), 1997, pp. 731-735
MUSCULAR METASTASIS AS THE FIRST MANIFEST ATION OF AN ADENOCARCINOMA
Authors: PERRIN AE GOICHOT B GREGET M LIOURE B DUFOUR P MARCELLIN L IMLER M
Citation: Ae. Perrin et al., MUSCULAR METASTASIS AS THE FIRST MANIFEST ATION OF AN ADENOCARCINOMA, La Revue de medecine interne, 18(4), 1997, pp. 328-331
MYELOPROLIFERATIVE SYNDROME
Authors: PETORIN C GOICHOT B VINZIO S LIOURE B IMLER M
Citation: C. Petorin et al., MYELOPROLIFERATIVE SYNDROME, La Revue de medecine interne, 18, 1997, pp. 330-331
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA
Authors: GUARDIOLA P ESPEROU H CAZALSHATEM D IFRAH N JOUET JP BUZYN A SUTTON L GRATECOS N TILLY H LIOURE B GLUCKMAN E
Citation: P. Guardiola et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA, British Journal of Haematology, 98(4), 1997, pp. 1004-1009
AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - ANALYSIS OF RISK-FACTORS FOR 4388 PATIENTS BY THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM)
Authors: SOCIE G CAHN JY CARMELO J VERNANT JP JOUET JP IFRAH N MILPIED N MICHALLET M LIOURE B PICO JL WITZ F MOLINA L FISCHER A BARDOU VJ GLUCKMAN E REIFFERS J
Citation: G. Socie et al., AVASCULAR NECROSIS OF BONE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - ANALYSIS OF RISK-FACTORS FOR 4388 PATIENTS BY THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE (SFGM), British Journal of Haematology, 97(4), 1997, pp. 865-870
COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA
Authors: HAROUSSEAU JL CAHN JY PIGNON B WITZ F MILPIED N DELAIN M LIOURE B LAMY T DESABLENS B GUILHOT F CAILLOT D ABGRALL JF FRANCOIS S BRIERE J GUYOTAT D CASASSUS P AUDHUY B TELLIER Z HURTELOUP P HERVE P
Citation: Jl. Harousseau et al., COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA, Blood, 90(8), 1997, pp. 2978-2986
PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION OF PERIPHERAL-BLOOD STEM-CELLS MOBILIZED EITHER WITH G-CSF OR G-CSF PLUS STEM-CELL FACTOR IN MYELOMA PATIENTS
Authors: BOHBOT A MALOISEL F ALLAM A KARCHER V FARADJI A OBERLING F LIOURE B
Citation: A. Bohbot et al., PHENOTYPIC AND FUNCTIONAL-CHARACTERIZATION OF PERIPHERAL-BLOOD STEM-CELLS MOBILIZED EITHER WITH G-CSF OR G-CSF PLUS STEM-CELL FACTOR IN MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 4200-4200
AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP
Authors: LIOURE B WITZ F DECONNINCK E DELAIN M SOLARY E BERTHOU C AUDHUY B FRANCOIS S GUYOTAT D SADDOUN A PIGNON B HAROUSSEAU JL OBERLING F
Citation: B. Lioure et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) REPRESENTS THE BEST CONSOLIDATION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 2ND COMPLETE REMISSION (CR) - A RETROSPECTIVE STUDY OF THE GOELAMS GROUP, Blood, 90(10), 1997, pp. 1710-1710
IDARUBICIN AND HIGH-DOSE CYTARABINE - A NEW SALVAGE TREATMENT FOR REFRACTORY OR RELAPSING NON-HODGKINS-LYMPHOMA
Authors: DUFOUR P MORS R BERTHAUD P LAMY T BERGERAT JP HERBRECHT R MALOISEL F AUDHUY B LIOURE B GIRON C HURTELOUP P OBERLING F
Citation: P. Dufour et al., IDARUBICIN AND HIGH-DOSE CYTARABINE - A NEW SALVAGE TREATMENT FOR REFRACTORY OR RELAPSING NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 22(3-4), 1996, pp. 329-334
CD34 CELL SELECTION FROM CRYOPRESERVED PERIPHERAL-BLOOD STEM-CELLS AFTER THAWING - TECHNICAL ASPECTS
Authors: BOHBOT A LIOURE B FARADJI A ALLAM A LAPLACE A OBERLING F
Citation: A. Bohbot et al., CD34 CELL SELECTION FROM CRYOPRESERVED PERIPHERAL-BLOOD STEM-CELLS AFTER THAWING - TECHNICAL ASPECTS, Experimental hematology, 24(9), 1996, pp. 137-137
AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY
Authors: CAHN JY HAROUSSEAU JL PIGNON B WITZ F DELAIN M LIOURE B LAMY T SOLARY E DESABLENS B BRIERE J CASSASUS P AUDHUY B POLIN V HURTELOUP P TELLIER Z
Citation: Jy. Cahn et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT SUPERIOR TO INTENSIVE CONSOLIDATION CHEMOTHERAPY (ICC) FOR POSTREMISSION THERAPY IN ADULT ACUTE MYELOBLASTIC-LEUKEMIA (AML) - FINAL ANALYSIS OF THE GOELAMS STUDY, Experimental hematology, 24(9), 1996, pp. 671-671
POSITIVE SELECTION OF CD34(-BLOOD STEM-CELLS AFTER THAWING - TECHNICAL ASPECTS AND CLINICAL USE() CELLS FROM CRYOPRESERVED PERIPHERAL)
Authors: BOHBOT A LIOURE B FARADJI A SCHMITT M CUILLEROT JM LAPLACE A OBERLING F
Citation: A. Bohbot et al., POSITIVE SELECTION OF CD34(-BLOOD STEM-CELLS AFTER THAWING - TECHNICAL ASPECTS AND CLINICAL USE() CELLS FROM CRYOPRESERVED PERIPHERAL), Bone marrow transplantation, 17(2), 1996, pp. 259-264
CARBOPLATIN-CYCLOPHOSPHAMIDE IN STAGE IC- IV OVARIAN-CARCINOMA - A RETROSPECTIVE STUDY OF 101 CASES
Authors: PETIT T DUFOUR P BARRATS JC MALOISEL F DUCLOS B GIRON C LIOURE B DELLENBACH P RENAUD R RITTER J AUDHUY B BERGERAT JP OBERLING F
Citation: T. Petit et al., CARBOPLATIN-CYCLOPHOSPHAMIDE IN STAGE IC- IV OVARIAN-CARCINOMA - A RETROSPECTIVE STUDY OF 101 CASES, Bulletin du cancer, 83(7), 1996, pp. 566-572
TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE
Authors: PIGNON B WITZ F DESABLENS B LEPRISE PY FRANCOIS S LINASSIER C BERTHOU C CAILLOT D LIOURE B CAHN JY CASASSUS P SADOUN A AUDHUY B GUYOTAT D BRIERE J VILQUE JP BARANGER L POLIN V BERTHAUD P HURTELOUP P HERVE P HAROUSSEAU JL
Citation: B. Pignon et al., TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN PATIENTS AGED 50-65 - IDARUBICIN IS MORE EFFECTIVE THAN ZORUBICIN FOR REMISSION INDUCTION AND PROLONGED DISEASE-FREE SURVIVAL CAN BE OBTAINED USING A UNIQUE CONSOLIDATION COURSE, British Journal of Haematology, 94(2), 1996, pp. 333-341
DISSEMINATED CUNNINGHAMELLA-ECHINULATA INFECTION IN A LYMPHOMA PATIENT
Authors: HERBRECHT R KURTZ JE KOENIG H WALLER J MALOISEL F LIOURE B LETSCHER V DEBIEVRE C OBERLING F
Citation: R. Herbrecht et al., DISSEMINATED CUNNINGHAMELLA-ECHINULATA INFECTION IN A LYMPHOMA PATIENT, Blood, 88(10), 1996, pp. 2873-2873
NEW ASSOCIATION OF HIGH-DOSE MITOXANTRONE (MTX), CARBOPLATIN (CBCDA) AND VP16 AS TREATMENT FOR RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: LIOURE B MOREAU P WITZ F WITZ B VILQUE JP FRANCOIS S BRION A DELAIN M CASASSUS P OJEDA M CAHN JY OBERLING F HAROUSSEAU JL
Citation: B. Lioure et al., NEW ASSOCIATION OF HIGH-DOSE MITOXANTRONE (MTX), CARBOPLATIN (CBCDA) AND VP16 AS TREATMENT FOR RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML), Blood, 88(10), 1996, pp. 848-848
Risultati: 1-25 | 26-44